Literature DB >> 11523212

Study on Fas/Fas-L expression in liver tissue and hepatocyte apoptosis in patients with hepatitis gravis.

Q Xia1, S Shi.   

Abstract

To explore the expression of Fas/Fas-L in liver tissue of hepatitis gravis patients and its implication in hepatocyte apoptosis, Fas/Fas-L expression and cell apoptosis was detected by the means of inmmunohistochemistry and terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL). It was found that in the 20 patients with clinical hepatitis gravis, Fas in hepatocytes showed strong expression and Fas-L also showed intensive expression in infiltrating lymphocytes and scattering hepatocytes. The apoptosis existed in all the samples, scattering in the areas of inflammatory, necrotic area and hepatic lobule. It was suggested that the overexpression of Fas/Fas-L could cause the death of hepatocytes and thus the occurrence of hepatitis gravis. The apoptosis caused by Fas might be one of the important pathogeneses of hepatitis gravis. Among the detected samples, apoptosis and necrosis coexisted, indicating that both two types of cellular death were closely associated with the pathogenesis of hepatitis gravis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523212     DOI: 10.1007/BF02888071

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  8 in total

1.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Authors:  D Kägi; F Vignaux; B Ledermann; K Bürki; V Depraetere; S Nagata; H Hengartner; P Golstein
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

Review 2.  FasL expression on epithelial cells: the Bottazzo-Feldman hypothesis revisited.

Authors:  C M Dayan; K A Elsegood; R Maile
Journal:  Immunol Today       Date:  1997-05

Review 3.  CD95-induced apoptosis in human liver disease.

Authors:  P R Galle; P H Krammer
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

Review 4.  [Involvement of Fas and Fas ligand in case of human fulminant hepatitis].

Authors:  K Ryo; Y Kamogawa; K Yamauchi; N Hayashi
Journal:  Nihon Rinsho       Date:  1996-07

5.  Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.

Authors:  K Ando; K Hiroishi; T Kaneko; T Moriyama; Y Muto; N Kayagaki; H Yagita; K Okumura; M Imawari
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

6.  Essential roles of the Fas ligand in the development of hepatitis.

Authors:  T Kondo; T Suda; H Fukuyama; M Adachi; S Nagata
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

7.  Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.

Authors:  F Gantner; M Leist; A W Lohse; P G Germann; G Tiegs
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

Review 8.  The Fas death factor.

Authors:  S Nagata; P Golstein
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.